Ken Fisher’s Lexicon Pharmaceuticals LXRX Stock Holding History

Ken Fisher’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-523,394	Closed	-$1.2M	–	1232
2023 Q2	$1.2M	Sell	523,394 -126,332	-19%	-$335K	﹤0.01%	743
2023 Q1	$1.58M	Sell	649,726 -70,517	-10%	-$162K	﹤0.01%	690
2022 Q4	$1.38M	Buy	720,243 +114,715	+19%	+$244K	﹤0.01%	716
2022 Q3	$1.45M	Hold	605,528	–	–	﹤0.01%	623
2022 Q2	$1.13M	Buy	605,528 +237,334	+64%	+$453K	﹤0.01%	616
2022 Q1	$770K	Buy	368,194 +197,424	+116%	+$547K	﹤0.01%	653
2021 Q4	$673K	Buy	+170,770	New	+$829K	﹤0.01%	703

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Ken Fisher's LXRX Position: Q3 2023 in Review

Ken Fisher sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2023, closing a stake of 523,394 shares — an estimated $1.2M sold.

Ken Fisher first reported a position in LXRX in Q4 2021 and held it in 7 quarters. The position peaked at $1.58M in Q1 2023. 112 funds tracked by Wall St. Rank hold LXRX as of Q3 2023.

Ken Fisher reported no remaining Lexicon Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Ken Fisher sold 523,394 Lexicon Pharmaceuticals shares in Q3 2023, an estimated $1.2M.
Ken Fisher first reported a position in Lexicon Pharmaceuticals in Q4 2021 and held it in 7 quarters.
Ken Fisher's Lexicon Pharmaceuticals position peaked at $1.58M in Q1 2023.
112 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2023.

Based on Fisher Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.